CLINICAL EFFICACY AND SAFETY OF INSULIN ASPART COMPARED WITH REGULAR HUMAN INSULIN IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS RECEIVING PRANDIAL INSULIN REGIMEN - A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
|
作者
Wojciechowski, P. [1 ]
Niemczyk-Szechowska, P. [1 ]
Olewinska, E. [1 ]
Jaros, P. [1 ]
Jurkiewicz, B. [2 ]
Skarzynska-Duk, J. [2 ]
Mlalecki, M. T. [3 ]
Rys, P. [1 ]
机构
[1] HTA Consulting, Krakow, Poland
[2] Novo Nordisk Pharma, Warsaw, Poland
[3] Jagiellonian Univ, Coll Med, Krakow, Poland
关键词
D O I
10.1016/j.jval.2014.03.1390
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB4
引用
收藏
页码:A238 / A238
页数:1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OF FASTER ASPART COMPARED WITH INSULIN ASPART IN TYPE 1 DIABETES
    Klonoff, D.
    Evans, M.
    Lane, W.
    Kempe, H. P.
    Renard, E.
    DeVries, H.
    Graungaard, T.
    Hyseni, A.
    Battelino, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A32 - A33
  • [22] Comparison of clinical effectiveness and safety of glulisine versus insulin lispro, aspart and regular human insulin in patients with type 1 and 2 diabetes
    Walczak, J.
    Borowiack, E.
    Kolodziej, K.
    Lis, J.
    Gierczynski, J.
    Nogas, G.
    VALUE IN HEALTH, 2008, 11 (03) : A219 - A219
  • [23] Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus
    Heller, Simon
    Bode, Bruce
    Kozlovski, Plamen
    Svendsen, Anne Louise
    JOURNAL OF DIABETES, 2013, 5 (04) : 482 - 491
  • [24] SAFETY AND EFFECTIVENESS OF INSULIN ANALOGUES VERSUS HUMAN INSULIN IN TYPE 2 DIABETES; A SYSTEMATIC REVIEW AND META-ANALYSIS
    Davari, M.
    Amani, B.
    Gharibnaseri, Z.
    Dehghani, M.
    Zakeri, H.
    Khorasan, E.
    Varmaghani, M.
    VALUE IN HEALTH, 2017, 20 (09) : A474 - A474
  • [25] Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
    Rys, Przemyslaw
    Wojciechowski, Piotr
    Rogoz-Sitek, Agnieszka
    Niesyczynski, Grzegorz
    Lis, Joanna
    Syta, Albert
    Malecki, Maciej T.
    ACTA DIABETOLOGICA, 2015, 52 (04) : 649 - 662
  • [26] Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
    Przemyslaw Rys
    Piotr Wojciechowski
    Agnieszka Rogoz-Sitek
    Grzegorz Niesyczyński
    Joanna Lis
    Albert Syta
    Maciej T. Malecki
    Acta Diabetologica, 2015, 52 : 649 - 662
  • [27] Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Alhmoud, Eman N.
    Saad, Mohamed Omar
    Omar, Nabil Elhadi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [28] Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis
    Qiao, Yong-Chao
    Ling, Wei
    Pan, Yan-Hong
    Chen, Yin-Ling
    Zhou, Dan
    Huang, Yan-Mei
    Zhang, Xiao-Xi
    Zhao, Hai-Lu
    ONCOTARGET, 2017, 8 (39) : 66504 - 66515
  • [29] The Effect of Regular Exercise on Insulin Sensitivity in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Way, Kimberley L.
    Hackett, Daniel A.
    Baker, Michael K.
    Johnson, Nathan A.
    DIABETES & METABOLISM JOURNAL, 2016, 40 (04) : 253 - 271
  • [30] Insulin aspart compared to regular insulin and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
    Arslanian, S
    Foster, C
    Wright, NM
    Stender, S
    Hales, P
    Hale, D
    DIABETOLOGIA, 2005, 48 : A327 - A327